Literature DB >> 2614038

Electrical properties of developing rat heart. Effects of dexamethasone.

Z J Penefsky1, F V McCann.   

Abstract

Action potentials recorded from perinatal rat ventricles exhibited a plateau (phase 2), followed by a rapid repolarization characteristics of all mammalian ventricular cells. Within the second postnatal week, a number of distinct changes occurred in the contour of action potentials. An early slow depolarization, at the foot of the action potential, preceded the beginning of phase zero. The early slow depolarization was observed until day 12 and disappeared by day 13. A second slow depolarization occurred during the terminal phase of the rapid upstroke of the action potential, persisted through day 13 and disappeared by day 14. On day 12, what had been a homogeneous contour of action potentials seen during the first week converted into a heterogeneous contour. Occasionally, action potentials similar to those recorded from Purkinje fibres in adult heart were recorded from hearts as young as 12 days. By day 14, signs of a spike (the hallmark of action potentials from adult heart) were apparent in some fibres. Treatment of newborn rats with dexamethasone on the second day after birth prevented the disappearance of the second slow depolarization. In adult and aged rat hearts, dexamethasone treatment induced a slow depolarization and a plateau in the region of overshoot. In view of the time-dependent change of the second slow depolarization it is suggested that this phase of the action potential is influenced by the levels of circulating glucocorticoid in developing heart and by changes in calcium sensitivity observed in this species. Heterogeneity of action potentials observed on day 12 postnatal may precede structural differentiation of myofilaments.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2614038

Source DB:  PubMed          Journal:  J Dev Physiol        ISSN: 0141-9846


  1 in total

1.  Precordial T-wave inversion of "cardiac memory" pattern after high-dose methylprednisolone pulse therapy.

Authors:  Johanna Rottensteiner; Angelika Kaneppele; Ingrid Stockner; Carmen Ladurner; Georgio Panizza; Christian J Wiedermann
Journal:  Intern Emerg Med       Date:  2008-02-15       Impact factor: 3.397

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.